SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
COVID-19: Epidemiologic and Clinical Insights
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
10 of
10
|
COVID Incidence and Severity in Persons With Reinfection vs Post-Vaccination Breakthrough Infection (ABSTRACT
132)
Adeel A. Butt
Weill Cornell Medicine, New York, NY, USA
MRNA Vaccine Versus Hybrid Immunity Against COVID-19 Among People With HIV During Omicron Wave (ABSTRACT
133)
Asa Tapley
Fred Hutchinson Cancer Research Center, Seattle, WA, USA
SARS-CoV-2 Viral Clearance and Evolution Varies by Extent of Immunodeficiency (ABSTRACT
134)
Yijia Li
University of Pittsburgh, Pittsburgh, PA, USA
Analysis of Emergent SARS-CoV-2 Antiviral Resistance and Its Association With Virologic Rebound (ABSTRACT
135)
Trevor J. Tamura
Brigham and Women's Hospital, Boston, MA, USA
QUESTIONS AND ANSWERS (Part 1)
Molnupiravir Does Not Increase 3CLpro Resistance Mutations When Co-Administered With Nirmatrelvir/r (ABSTRACT
136)
Shuntai Zhou
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Mini-Lecture: Progress in Understanding the Mechanisms of Long COVID (ABSTRACT
137)
Annukka A. R. Antar
The Johns Hopkins University, Baltimore, MD, USA
Multimodal Assessment of Antigen Persistence in the Post-Acute Phase of SARS-CoV-2 Infection (ABSTRACT
138)
Michael J. Peluso
University of California San Francisco, San Francisco, CA, USA
QUESTIONS AND ANSWERS (Part 2)
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
10 of
10
|
